Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Options Trading Activity and Outlook for Oracle NYSE ORCL March 15 2024

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Finance_Budgeting (1)
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

The options trading activity for Oracle (NYSE: ORCL) on March 15, 2024, reveals a positive outlook from savvy investors. A total of 27 unusual options trades were detected by our scanner, showcasing a split sentiment of 51% bullish and 48% bearish among major players in the market. Among these trades, there were 10 put options valued at $520,606 and 17 call options valued at $1,244,496.

Investors with significant stakes are eyeing a price range of $95.0 to $135.0 for Oracle in the next three months based on recent trading patterns. Today’s trading saw an average open interest of 3576.65 for Oracle options, with a total volume of 5,071.00. Noteworthy options activities in the past month include:

– ORCL CALL SWEEP BULLISH expiring on 01/17/25 with a strike price of $130.00, a total trade price of $196.4K, open interest of 3.1K, and volume of 145.
– ORCL CALL TRADE BULLISH expiring on 03/15/24 with a strike price of $110.00, a total trade price of $193.8K, open interest of 10.0K, and volume of 267.
– ORCL CALL SWEEP BEARISH expiring on 03/15/24 with a strike price of $95.00, a total trade price of $156.9K, open interest of 300, and volume of 91.

Oracle Corporation (ORCL) Stock Market Performance on March 15, 2024: Analysis and Insights

On March 15, 2024, Oracle Corporation (ORCL) saw some mixed performance in the stock market. Despite trading near the top of its 52-week range and above its 200-day simple moving average, the stock experienced a slight decrease in price.

At the opening bell, ORCL started the day at $123.98, which was $1.55 lower than its previous close. Throughout the trading day, the price of ORCL shares dropped by $0.74, representing a 0.59% decrease from the previous day’s closing price.

While the slight drop in price may be concerning to some investors, it’s important to note that fluctuations in stock prices are common and can be influenced by a variety of factors.

Overall, ORCL’s performance on March 15, 2024, may not have been as strong as some investors had hoped, but it’s essential to take a long-term view when evaluating stock performance. As always, it’s important for investors to stay informed and make decisions based on their own financial situation and investment objectives.

Oracle Corporation Reports Strong Financial Performance with Revenue Up 17.7% in 2024

On March 15, 2024, Oracle Corporation (ORCL) reported its financial performance for the past year and the third quarter of the fiscal year. According to data from CNN Money, the tech giant generated a total revenue of $49.95 billion over the past year, representing a 17.7% increase compared to the previous year.

Net income for Oracle stood at $8.50 billion for the past year, marking a 26.59% increase from the previous year.

Earnings per share (EPS) for Oracle were reported at $3.07 for the past year, showing a 27.5% increase from the previous year.

Overall, Oracle’s financial performance over the past year has been strong, with significant increases in total revenue, net income, and EPS. However, the slight decrease in net income and EPS in the third quarter may have impacted investor sentiment. Investors should closely monitor Oracle’s stock performance in the coming days to gauge the impact of these financial results on the company’s valuation.

Tags: ORCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

Food Retailers Stock Bull Market

Analyst Upgrades Superior Group of Companies to Outperform with Increased Price Target

Finances-and-tech

Analyst Ratings and Price Targets for CarGurus NASDAQ CARG

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com